Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(3)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05998902Phase 3Recruiting

Optimizing Early Nutrition Support in Severe Stroke-2

Role: collaborator

NCT05487417Phase 4Recruiting

Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy

Role: collaborator

NCT04686877Not ApplicableRecruiting

Safety and Efficacy of Stereotactic Aspiration Plus Urokinase in Deep Intracerebral Hemorrhage Evacuation

Role: collaborator

NCT06512688Recruiting

Establishing Reference Ranges for Fat-Soluble Vitamins in Healthy Chinese Adults

Role: collaborator

NCT05745805Recruiting

Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China

Role: collaborator

NCT02982668Not ApplicableTerminated

Optimizing Early Enteral Nutrition in Severe Stroke

Role: collaborator

NCT02982655Not ApplicableCompleted

Controlling Hypertension After Severe Cerebrovascular Event

Role: collaborator

All 7 trials loaded